The CCR5/CXCR4-independent phenotype was demonstrated either in ccr5 ∆32/∆32 peripheral blood mononuclear cells (PBMC) infection, and by testing the in vitro resistance to CCR5 and CXCR4 targeted inhibitors [7,32]. The gene discussed is CCR5; the disease is infection.